Docetaxel Administration and Dosage

Standard Dosing by Indication

• The National Comprehensive Cancer Network recommends a standard regimen of 75 mg/m² IV over 1 hour every 3 weeks for metastatic castration-resistant prostate cancer, which must be combined with prednisone 5 mg orally twice daily continuously 1
• For ovarian cancer, a standard regimen of 60-75 mg/m² IV over 1 hour followed by carboplatin AUC 5-6 IV over 1 hour on day 1, every 3 weeks for 6 cycles, is particularly useful for patients at high risk for neuropathy 2, 3, 4

Alternative Dosing Schedules

• The National Comprehensive Cancer Network suggests that weekly docetaxel is an option for patients where myelosuppression risk is unacceptable, with a dose of 30-40 mg/m² IV weekly for 6 of 8 weeks, or 40 mg/m² weekly for 6 weeks followed by 2-week rest 6

Dose Modifications and Contraindications

• The National Comprehensive Cancer Network notes that the docetaxel/carboplatin regimen has an increased neutropenia risk compared to paclitaxel regimens 3, 4, 5

Common Pitfalls to Avoid

• The European Association of Urology advises against assessing treatment response too early in prostate cancer, and recommends evaluating PSA response at approximately 12 weeks 7